AIM CIK: 946644

AIM ImmunoTech Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0.14
FY25:
−0.04
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.8
FY22:
−19.9
FY23:
−31.9
FY24:
−19.8
FY25:
−11.7
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−15.9
FY25:
−12.7
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−17.3
FY25:
−14.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.1
FY22:
−19.4
FY23:
−29.0
FY24:
−17.3
FY25:
−14.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data